Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bmy crawled time : 09:00 save search
Bristol Myers Squibb Prices $13 Billion of Senior Unsecured Notes
Published: 2024-02-15 (Crawled : 09:00) - biospace.com/
RYZB | $62.49 0.03% 280K
|
|
| O: 0.01%
H: 0.03%
C: -0.02%
BMY | $48.72 -0.55% 250K
|
Health Technology
|
| O: 0.25%
H: 2.59%
C: 0.88%
KRTX | $329.83 0.0% 1.9M
|
Health Technology
|
| O: 0.75%
H: 0.19%
C: -0.46%
Bristol Myers Squibb Presents New Zeposia (ozanimod) Data on Long-Term Disease Progression and Cognition in Patients with Relapsing Forms of Multiple Sclerosis
Published: 2023-10-11 (Crawled : 09:00) - biospace.com/
BMY | $48.72 -0.55% 250K
|
Health Technology
|
| O: 0.16%
H: 0.73%
C: 0.3%
disease sclerosis
Nanotechnology Drug Delivery Market to Reach $209.5 Billion, Globally, by 2032 at 9.1% CAGR: Allied Market Research
Published: 2023-07-19 (Crawled : 09:00) - prnewswire.com
AZNCF | News | $140.3 1.13% 0
|
Health Technology
|
| O: 0.47%
H: 1.47%
C: 1.47%
NVSEF | News | $96.0 0.94% 0
|
Health Technology
|
| O: -1.97%
H: 0.0%
C: 0.0%
TEVA | $13.055 0.35% 490K
|
Health Technology
|
| O: 1.23%
H: 4.13%
C: 4.01%
NVS | News | $97.86 0.6% 420K
|
Health Technology
|
| O: 0.61%
H: 0.6%
C: -0.84%
BMY | $48.72 -0.55% 250K
|
Health Technology
|
| O: 0.19%
H: 1.19%
C: -0.1%
AZN | News | $71.19 0.48% 1M
|
Health Technology
|
| O: 1.5%
H: 0.75%
C: -0.32%
AMGN | News | $270.69 -1.04% 120K
|
Health Technology
|
| O: 0.18%
H: 0.67%
C: -0.4%
drug reach research market
Dr. Reddy's Laboratories Announces Approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)
Published: 2021-10-19 (Crawled : 09:00) - biospace.com/
BMY | $48.72 -0.55% 250K
|
Health Technology
|
| O: 0.42%
H: 0.8%
C: 0.72%
food fda drug approval
Exelixis Announces CABOMETYX® in Combination with OPDIVO® Provides Efficacy Benefits Regardless of Prior Nephrectomy in Patients with Previously Untreated Advanced Renal Cell Carcinoma Based on CheckMate -9ER Analysis Presented at ESMO 2021
Published: 2021-09-16 (Crawled : 09:00) - biospace.com/
TAK | News | $13.245 -1.01% 120K
|
Health Technology
|
| O: 0.41%
H: 1.11%
C: 0.76%
BMY | $48.72 -0.55% 250K
|
Health Technology
|
| O: -0.23%
H: 0.31%
C: -1.02%
EXEL | $23.38 0.39% 43K
|
Health Technology
|
| O: 0.0%
H: 0.83%
C: 0.34%
renal cell carcinoma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
CZOO | $9.98 100.0% 330K
|
AMST | $3.48 74.0% 21M
|
Technology Services
BOF | $1.78 52.14% 15M
|
SYRA | $1.5 51.23% 1M
|
n/a
CSSE 4 | $0.2184 43.4% 36M
|
Consumer Services
RILY | $30.325 39.62% 6.8M
|
Finance
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.445 26.19% 980K
|
Information
RBBN 4 | $3.21 24.9% 580K
|
Electronic Technology
LICN | $0.6987 24.77% 4.4M
|
Your saved searches
Save your searches and get alerts when important news are released.